Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Bioorganic & medicinal chemistry, 2015-05, Vol.23 (9), p.1975-1981
2015
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Novel arylazopyrazole inhibitors of cyclin-dependent kinases
Ist Teil von
  • Bioorganic & medicinal chemistry, 2015-05, Vol.23 (9), p.1975-1981
Ort / Verlag
England: Elsevier Ltd
Erscheinungsjahr
2015
Quelle
MEDLINE
Beschreibungen/Notizen
  • [Display omitted] Here, we describe new 4-arylazo-3,5-diamino-1H-pyrazole derivatives developed from CAN508, one of the first inhibitors to show preference for transcriptional regulator cyclin-dependent kinase 9. By substituting nitrogen in the pyrazole ring and employing a heteroatom in the 4-aryl ring, we obtained more potent derivatives differing in their CDK-selectivity profiles. The antiproliferative and anti-CDK kinase activities of the novel arylazopyrazoles were examined. The cellular effect of compound IVc was studied on MCF-7 cells synchronized by various methods and compared with other selective CDK inhibitors. The results demonstrated that IVc shows a preference for CDK4 and CDK1. In contrast to cytostatic effects induced by IVc in MCF-7 and K562 cells, we observed apoptotic activities in the RPMI-8226 cell line, which were confirmed by detecting active caspases by different biochemical assays.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX